Functional recombinant human anti-HAV antibody expressed in milk of transgenic mice

Transgenic Research

Volumn 18, Issue 3, 2009, Pages 445-453

  Zhang, Ran ^a   Rao, Man ^a   Li, Chuan ^b   Cao, Jingyuan ^b   Meng, Qinglin ^b   Zheng, Min ^c   Wang, Meili ^c   Dai, Yunping ^a   Liang, Mifang ^b   Li, Ning ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b NATIONAL INSTITUTE FOR VIRAL DISEASE CONTROL AND PREVENTION   (China)

^c Beijing Genprotein Biotechnology Company   (China)

Author keywords

Hepatitis A virus; Milk; Monoclonal antibody; Transgenic mice

Indexed keywords

HEPATITIS A ANTIBODY; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; FEMALE; HEPATITIS A VIRUS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MILK; MOUSE; PREGNANCY; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; FEMALE; HEPATITIS A ANTIBODIES; HEPATITIS A VIRUS, HUMAN; HUMANS; MICE; MICE, TRANSGENIC; MILK; PREGNANCY; RECOMBINANT PROTEINS;

ANIMALIA; HEPATITIS A VIRUS; MUS MUSCULUS;

EID: 67349190591     PISSN: 09628819     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11248-008-9241-0     Document Type: Article

References (42)

1. JY Cao MF Liang QL Meng XF Wang YG Xu KQ Guo MY Zhan SL Bi DX Li 2004 Baculovirus expression of two human recombinant neutralizing IgG monoclonal antibodies to hepatitis A virus Chin J Exp Clin Virol 18 20 23
2. J Castilla B Pintado I Sola JM Sanchez-Morgado L Enjuanes 1998 Engineering passive immunity in transgenic mice secreting virus-neutralizing antibodies in milk Nat Biotechnol 16 349 354 10.1038/nbt0498-349 (Pubitemid 28164654)
3. Castillo FJ (1999) Production of clinical grade monoclonal antibodies. In: Presentation at international business communications fifth annual antibody production & downstream processing conference, pp 17-19
4. CDC 1999 Prevention of Hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) Morb Mortal Wkly Rep 48 RR12 1 37
5. CDC 2006 Prevention of Hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) Morb Mortal Wkly Rep 55 RR07 1 23
6. JH Chung AC Bell G Felsenfeld 1997 Characterization of the chicken beta-globin insulator Proc Natl Acad Sci USA 94 575 580 10.1073/pnas.94.2.575 (Pubitemid 27053675)
7. AJ Clark A Cowper R Wallace G Wright JP Simons 1992 Rescuing transgene expression by co-integration Biotechnology (NY) 10 1450 1454 10.1038/nbt1192-1450
8. L Di Giammarino JL Dienstag 2005 Hepatitis A-the price of progress N Engl J Med 353 944 946 10.1056/NEJMe058152 (Pubitemid 41247937)
9. A Dove 2002 Uncorking the biomanufacturing bottleneck Nat Biotechnol 20 777 779 10.1038/nbt0802-777
10. MK Dyck D Lacroix F Pothier MA Sirard 2003 Making recombinant proteins in animals-different systems, different applications Trends Biotechnol 21 394 399 10.1016/S0167-7799(03)00190-2 (Pubitemid 37028312)
11. SS Farid 2007 Process economics of industrial monoclonal antibody manufacture J Chromatogr B Analyt Technol Biomed Life Sci 848 8 18 10.1016/j.jchromb.2006.07.037 (Pubitemid 46367764)
12. U Gottschalk 2005 Downstream processing of monoclonal antibodies: from high dilution to high purity BioPharm Int 18 42 52 (Pubitemid 40851994)
13. SC Hadler HM Webster JJ Erben JE Swanson JE Maynard 1980 Hepatitis A in day-care centers. A community-wide assessment N Engl J Med 302 1222 1227 (Pubitemid 10112394)
14. Hogan B, Beddington R, Costantini F, Lacy E (1994) Manipulating the mouse embryo, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
15. LM Houdebine 2002 Antibody manufacture in transgenic animals and comparisons with other systems Curr Opin Biotechnol 13 625 629 10.1016/S0958-1669(02)00362-2 (Pubitemid 35448067)
16. CL Keefer 2004 Production of bioproducts through the use of transgenic animal models Anim Reprod Sci 82-83 5 12 10.1016/j.anireprosci.2004.04.010 (Pubitemid 39027045)
17. JS Keystone JH Hershey 2008 The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule Int J Infect Dis 12 3 11 10.1016/j.ijid.2007.04.012
18. SJ Kim MH Jang JT Stapleton SO Yoon KS Kim ES Jeon HJ Hong 2004 Neutralizing human monoclonal antibodies to hepatitis A virus recovered by phage display Virology 318 598 607 10.1016/j.virol.2003.10.014 (Pubitemid 38224302)
19. AF Kolb L Pewe J Webster S Perlman CB Whitelaw SG Siddell 2001 Virus-neutralizing monoclonal antibody expressed in milk of transgenic mice provides full protection against virus-induced encephalitis J Virol 75 2803 2809 10.1128/JVI.75.6.2803-2809.2001 (Pubitemid 32185044)
20. S Kozlowski P Swann 2006 Current and future issues in the manufacturing and development of monoclonal antibodies Adv Drug Deliv Rev 58 707 722 10.1016/j.addr.2006.05.002 (Pubitemid 44255854)
21. S Krugman JP Giles J Hammond 1967 Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection JAMA 200 365 373 10.1001/jama.200.5.365 (Pubitemid 127780265)
22. OG Larralde R Martinez F Camacho N Amin A Aguilar A Talavera DI Stott EM Perez 2007 Identification of hepatitis A virus mimotopes by phage display, antigenicity and immunogenicity J Virol Methods 140 49 58 10.1016/j.jviromet. 2006.10.015 (Pubitemid 46201704)
23. J Limonta A Pedraza A Rodriguez FM Freyre AM Barral FO Castro R Lleonart CA Gracia JV Gavilondo J de la Fuente 1995 Production of active anti-CD6 mouse/human chimeric antibodies in the milk of transgenic mice Immunotechnology 1 107 113 10.1016/1380-2933(95)00010-0
24. N Lonberg 2005 Human antibodies from transgenic animals Nat Biotechnol 23 1117 1125 10.1038/nbt1135 (Pubitemid 41486393)
25. A MacGregor M Kornitschuk JG Hurrell NI Lehmann AG Coulepis SA Locarnini ID Gust 1983 Monoclonal antibodies against hepatitis A virus J Clin Microbiol 18 1237 1243 (Pubitemid 14239808)
26. WA Marasco J Sui 2007 The growth and potential of human antiviral monoclonal antibody therapeutics Nat Biotechnol 25 1421 1434 10.1038/nbt1363 (Pubitemid 350233138)
27. A Martin SM Lemon 2006 Hepatitis A virus: from discovery to vaccines Hepatology 43 S164 S172 10.1002/hep.21052 (Pubitemid 43303980)
28. A Molina M Valladares S Magadan D Sancho F Viedma I Sanjuan F Gambon F Sanchez-Madrid A Gonzalez-Fernandez 2003 The use of transgenic mice for the production of a human monoclonal antibody specific for human CD69 antigen J Immunol Methods 282 147 158 10.1016/j.jim.2003.08.007 (Pubitemid 37357040)
29. DL Newton D Pollock P DiTullio Y Echelard M Harvey B Wilburn J Williams HR Hoogenboom JC Raus HM Meade SM Rybak 1999 Antitransferrin receptor antibody-RNase fusion protein expressed in the mammary gland of transgenic mice J Immunol Methods 231 159 167 10.1016/S0022-1759(99)00154-4 (Pubitemid 30394731)
30. LJ Reed IL Muench 1938 A simple method of estimating fifty percent endpoints Am J Hyg 27 493 497
31. JM Reichert CJ Rosensweig LB Faden MC Dewitz 2005 Monoclonal antibody successes in the clinic Nat Biotechnol 23 1073 1078 10.1038/nbt0905-1073 (Pubitemid 41486385)
32. Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual, 3rd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
33. I Sola J Castilla B Pintado JM Sanchez-Morgado CB Whitelaw AJ Clark L Enjuanes 1998 Transgenic mice secreting coronavirus neutralizing antibodies into the milk J Virol 72 3762 3772 (Pubitemid 28188674)
34. Tang B, Yu S, Zheng M, Ding F, Zhao R, Zhao J, Dai Y, Li N (2008) High level expression of a functional human/mouse chimeric anti-CD20 monoclonal antibody in milk of transgenic mice. Transgenic Res 727-732. doi: 10.1007/s11248-007-9162-3
35. P Van Damme K Van Herck 2005 Effect of hepatitis A vaccination programs JAMA 294 246 248 10.1001/jama.294.2.246 (Pubitemid 41043796)
36. JC Victor AS Monto TY Surdina SZ Suleimenova G Vaughan OV Nainan MO Favorov HS Margolis BP Bell 2007 Hepatitis A vaccine versus immune globulin for postexposure prophylaxis N Engl J Med 357 1685 1694 10.1056/NEJMoa070546 (Pubitemid 350005150)
37. JS Wei R Tao WW Sun Q Jia C Li MF Liang 2004 Purification and characterization of recombinant human anti-HAV monoclonal antibody Chin J Biotechnol 20 257 261
38. CB Whitelaw AL Archibald S Harris M McClenaghan JP Simons AJ Clark 1991 Targeting expression to the mammary gland: intronic sequences can enhance the efficiency of gene expression in transgenic mice Transgenic Res 1 3 13 10.1007/BF02512991
39. PL Winokur JT Stapleton 1992 Immunoglobulin prophylaxis for hepatitis A Clin Infect Dis 14 580 586 (Pubitemid 8324576)
40. MW Young WB Okita EM Brown JM Curling 1997 Production of biopharmaceutical proteins in the milk of transgenic dairy animals Biopharm Int 10 34 38 (Pubitemid 27319275)
41. S Yu M Liang B Fan H Xu C Li Q Zhang D Li B Tang S Li Y Dai M Wang M Zheng B Yan Q Zhu N Li 2006 Maternally derived recombinant human anti-hantavirus monoclonal antibodies are transferred to mouse offspring during lactation and neutralize virus in vitro J Virol 80 4183 4186 10.1128/JVI.80.8.4183-4186.2006
42. W Zhang MJ Czupryn 2002 Free sulfhydryl in recombinant monoclonal antibodies Biotechnol Prog 18 509 513 10.1021/bp025511z (Pubitemid 34623225)